הצעות למענקים מחקריים מטעם חברת פייזר בנושא חיסונים במחלות אינפלמטוריות ובנושא פיתוח יכולות כתיבה מדעית לפרסום מאמרים

Request for Proposal (RFP)
Appropriate Immunisations in Adult Patients with Immune-Mediated Inflammatory Conditions

Date RFP Issued: February 15, 2018
Clinical Area: Immunisation in Inflammatory Conditions
Geographic Scope: All European countries (including Israel, Turkey and Russia), Australia, and New Zealand
Link to full RFP: Appropriate Immunisations in Adult Patients with Immune-Mediated Inflammatory Conditions
LOI Due Date: April 12, 2018

Specific Area of Interest: It is our intent to support education and quality improvement programmes that focus on ensuring that adult patients with immune-mediated inflammatory conditions (specifically rheumatoid arthritis, spondyloarthritis and inflammatory bowel disease) are receiving appropriate vaccinations, as determined by their age, gender, and specific clinical risk information such as age and use of concomitant therapies.

Questions regarding this RFP should be directed to jo.harbron@pfizer.com.

 

Pfizer announces a re-release of an RFP in collaboration with the British Medical Journal.
Pfizer and the British Medical Journal: Re-release of an RFP

Pfizer and the British Medical Journal are collaborating to offer a new opportunity focused on improving developing the clinical research and publication skills of doctors and healthcare researchers.

The mission of Pfizer Independent Grants for Learning & Change (IGLC) is to partner with the global healthcare community to improve patient outcomes in areas of mutual interest through support of measurable learning and change strategies. "Independent" means that the projects funded by Pfizer are the full responsibility of the recipient organization. Pfizer has no influence over any aspect of the projects and only asks for reports about the results and the impact of the projects in order to share them publicly.

The mission of the British Medical Journal (The BMJ) is to publish rigorous, accessible, and entertaining material that will help doctors and medical students in their daily practice, lifelong learning, and career development. As well as publishing research, BMJ (in collaboration with the University of San Francisco California (USFC)) has developed the "Research to Publication programme" which is part of BMJ's commitment to building medical research capabilities around the world. Research to Publication is a gold standard online programme of self-study courses to enable doctors and healthcare researchers to develop clinical research skills, write the best possible papers, and succeed in getting papers published.

Click the link or scroll down for detailed information regarding this RFP:
Developing Clinical Research and Publication Skills – EU AfME (Re-release)

Developing Clinical Research and Publication Skills – EU AfME (Re-release)

Request for Proposal (RFP)
Developing Clinical Research and
Publication Skills – EU AfME (Re-release)

Date RFP Issued: February 12, 2018
Clinical Area: All
Geographic Region: Countries in Europe, Africa and the Middle East (with the exception of the United Kingdom)
Link to full RFP: Developing Clinical Research and Publication Skills – AfME and EU (Re-release)
Submission Due Date: April 30, 2018

Specific Area of Interest:

In partnership with the British Medical Journal (BMJ), Pfizer is pleased to be able to invite healthcare and research organisations to apply for access to the BMJ's "Research to Publication" e-learning module. Research to Publication is an online programme of self-study courses to enable doctors and healthcare researchers to develop clinical research skills, write the best possible papers, and succeed in getting papers published. For more information on what the programme entails and how your institution may benefit from access, visit rtop.bmj.com*. Priority will be given to applications that include robust dissemination and implementation plans and those with lower income status (according to the World Bank Classification).

Successful applicants will receive access to Research to Publication for their organisation for 12 months which will be provided by the BMJ and funded by Pfizer. Successful applicants will not receive monetary grants.

*Please note that the Research to Publication e-learning module is intended for clinical researchers and is not intended to improve basic science research skills.

Questions regarding this RFP should be directed to jo.harbron@pfizer.com.

פורסם בקטגוריה חדשות , מאת מערכת האיגוד הישראלי לראומטולוגיה.